Literature DB >> 18391966

Signal sequence-independent membrane targeting of ribosomes containing short nascent peptides within the exit tunnel.

Thomas Bornemann1, Johannes Jöckel, Marina V Rodnina, Wolfgang Wintermeyer.   

Abstract

Ribosomes synthesizing inner membrane proteins in Escherichia coli are targeted to the translocon in the plasma membrane by the signal recognition particle (SRP) and the SRP receptor, FtsY. Here we show using a purified system that membrane targeting does not require an exposed signal-anchor sequence, as SRP-dependent targeting takes place with ribosomes containing short nascent peptides, with or without a signal-anchor sequence, within the peptide exit tunnel. Signaling from inside the tunnel involves ribosomal protein L23, which constitutes part of the SRP binding site. When nascent peptides emerge from the ribosome, the targeting complex is maintained with ribosomes exposing a signal-anchor sequence, whereas ribosomes exposing other sequences are released. These results indicate that ribosome-nascent chain complexes containing any nascent peptide within the exit tunnel can enter the SRP targeting pathway to be sorted at the membrane into ribosome-nascent chain complexes that synthesize either membrane or cytosolic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391966     DOI: 10.1038/nsmb.1402

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  83 in total

1.  YqjD is an inner membrane protein associated with stationary-phase ribosomes in Escherichia coli.

Authors:  Hideji Yoshida; Yasushi Maki; Shou Furuike; Akiko Sakai; Masami Ueta; Akira Wada
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Consequences of depletion of the signal recognition particle in Escherichia coli.

Authors:  David Wickström; Samuel Wagner; Louise Baars; A Jimmy Ytterberg; Mirjam Klepsch; Klaas J van Wijk; Joen Luirink; Jan-Willem de Gier
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

3.  Reprogramming chaperone pathways to improve membrane protein expression in Escherichia coli.

Authors:  Brent L Nannenga; François Baneyx
Journal:  Protein Sci       Date:  2011-07-07       Impact factor: 6.725

4.  The conformation of a nascent polypeptide inside the ribosome tunnel affects protein targeting and protein folding.

Authors:  Janine H Peterson; Cheryl A Woolhead; Harris D Bernstein
Journal:  Mol Microbiol       Date:  2010-08-20       Impact factor: 3.501

5.  Differences in the path to exit the ribosome across the three domains of life.

Authors:  Khanh Dao Duc; Sanjit S Batra; Nicholas Bhattacharya; Jamie H D Cate; Yun S Song
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

Review 6.  The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins.

Authors:  Günter Kramer; Daniel Boehringer; Nenad Ban; Bernd Bukau
Journal:  Nat Struct Mol Biol       Date:  2009-06       Impact factor: 15.369

7.  Conformation of the signal recognition particle in ribosomal targeting complexes.

Authors:  Iwona A Buskiewicz; Johannes Jöckel; Marina V Rodnina; Wolfgang Wintermeyer
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

Review 8.  Delivering proteins for export from the cytosol.

Authors:  Benedict C S Cross; Irmgard Sinning; Joen Luirink; Stephen High
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

9.  Multiple conformational switches in a GTPase complex control co-translational protein targeting.

Authors:  Xin Zhang; Christiane Schaffitzel; Nenad Ban; Shu-ou Shan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

10.  Single-molecule dynamics of the molecular chaperone trigger factor in living cells.

Authors:  Feng Yang; Tai-Yen Chen; Łukasz Krzemiński; Ace George Santiago; Won Jung; Peng Chen
Journal:  Mol Microbiol       Date:  2016-09-30       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.